Literature DB >> 487327

Decrease in the rate of protein synthesis by polysomes from cultured fibroblasts of patients and carriers with Duchenne muscular dystrophy.

M Boulé, M Vanasse, L Brakier-Gingras.   

Abstract

Polysomes extracted from cultured fibroblast cells isolated from patients with Duchenne muscular dystrophy (DMD), carriers of the disease, and normal controls were used for in vitro measurement of protein synthesis in a wheat germ extract system. It was observed that polysomes from patients and carriers (seven of each aged 17 years or older) exhibited a 3-fold and a 1.5-fold decrease in the rate of protein synthesis, respectively, as compared with controls. These results are discussed with a view to developing a sensitive and easily available assay for the detection of DMD carriers.

Entities:  

Mesh:

Year:  1979        PMID: 487327     DOI: 10.1017/s0317167100024008

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  5 in total

1.  Altered ribosomal protein synthesis in congenital non-progressive myopathy.

Authors:  H Pöche; E Kattner
Journal:  Klin Wochenschr       Date:  1987-12-01

Review 2.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

3.  Detection of Duchenne muscular dystrophy carriers: quantitative echography and creatine kinasemia.

Authors:  G Schapira; P Laugier; J Rochette; G Berger; P Katz; J Perrin
Journal:  Hum Genet       Date:  1987-01       Impact factor: 4.132

4.  Abnormal collagen metabolism in cultured skin fibroblasts from patients with Duchenne muscular dystrophy.

Authors:  H P Rodemann; K Bayreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

5.  Differential degradation of [35S]methionine polypeptides in Duchenne muscular dystrophy skin fibroblasts in vitro.

Authors:  H P Rodemann; K Bayreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.